AAAAAA

   
Results: 1-16 |
Results: 16
COMPARATIVE ANTIMICROBIAL ACTIVITY OF PIPERACILLIN-TAZOBACTAM TESTED AGAINST MORE THAN 5000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS- A REEVALUATION AFTER 5 YEARS
Authors: MARSHALL SA ALDRIDGE KE ALLEN SD FUCHS PC GERLACH EH JONES RN
Citation: Sa. Marshall et al., COMPARATIVE ANTIMICROBIAL ACTIVITY OF PIPERACILLIN-TAZOBACTAM TESTED AGAINST MORE THAN 5000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS- A REEVALUATION AFTER 5 YEARS, Diagnostic microbiology and infectious disease, 21(3), 1995, pp. 153-168
EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES
Authors: JONES RN SADER HS ERWIN ME ANDERSON SC ALDRIDGE KA ALLEN S ANHALT J APPELBAUM P ARRINGTON KL AYERS L BAKER C BEAVIS K BERGER J BERTHOLD G BIRNBAUM M BOYLE J BRECHER S BRECKENRIDGE R BROWN W BRUCKNER D CARROLL K CHAUDHARY S CLEARY T COCKERILL F COYLE M CRAWFORD V DALTON H DOERN G EDBERG S GELFAND M GERLACH EH GOODMAN N GORZYNSKI E GREEN P GROSCHEL D HANFF P HANNA B HARRELL L HAUGEN T HEAGREY M HUMPHRIES J ISENBERG H JENKINS S JONES E JORGENSEN J KAUFFMAN C KEISER J KOCKA F KOMINOS S LEVISON M LOCKWOOD W MANOS J MARTIN W MCLAUGHLIN J METCHOCK B MICKELSEN P MOODY J MORELLO J MOSTOW S MOTYL M MURRAY B MURRAY PR NOLTE F PARK C PEZZLO M PRICE M PUSCSH A REED K REIMER L RINALDI M RISTUCCIA A ROBINSON A ROSATI L SAUBOLLE M SCHALHAB J SCHULTZ G SCHWALBE R SEWELL D SHALES D SIERRA M SINNOTT J SLIFKIN M SMITH L SPIEGEL C STANECK J STEELEMOORE L STEIN G STEVENS D STRATTON C TAN J THOMAS J WAITES K WEINSTEIN M WELCH W WIN W WOODS G WRIGHT L YUNGBLUTH M ZWADYK P
Citation: Rn. Jones et al., EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES, Diagnostic microbiology and infectious disease, 21(2), 1995, pp. 85-93
MULTICENTER CLINICAL LABORATORY EVALUATION OF A BETA-LACTAMASE DISK ASSAY EMPLOYING A NOVEL CHROMOGENIC CEPHALOSPORIN, S1
Authors: DOERN GV JONES RN GERLACH EH WASHINGTON JA BIEDENBACH DJ BRUEGGEMANN A ERWIN ME KNAPP C RAYMOND J
Citation: Gv. Doern et al., MULTICENTER CLINICAL LABORATORY EVALUATION OF A BETA-LACTAMASE DISK ASSAY EMPLOYING A NOVEL CHROMOGENIC CEPHALOSPORIN, S1, Journal of clinical microbiology, 33(6), 1995, pp. 1665-1667
REVISED DISK DIFFUSION INTERPRETIVE CRITERIA FOR CEFACLOR, LORACARBEF, CEFPROZIL AND CEFIXIME WHEN TESTING HAEMOPHILUS-INFLUENZAE ON HAEMOPHILUS TEST MEDIUM
Authors: DOERN GV JONES RN GERLACH EH HINDLER J STAMAND R
Citation: Gv. Doern et al., REVISED DISK DIFFUSION INTERPRETIVE CRITERIA FOR CEFACLOR, LORACARBEF, CEFPROZIL AND CEFIXIME WHEN TESTING HAEMOPHILUS-INFLUENZAE ON HAEMOPHILUS TEST MEDIUM, European journal of clinical microbiology & infectious diseases, 13(6), 1994, pp. 481-489
MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS
Authors: BALE MJ JONES RN ERWIN ME MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68
VALIDATION OF NCCLS MACROLIDE (AZITHROMYCIN, CLARITHROMYCIN, AND ERYTHROMYCIN) INTERPRETIVE CRITERIA FOR HAEMOPHILUS-INFLUENZAE TESTED WITHTHE HAEMOPHILUS TEST MEDIUM
Authors: JONES RN DOERN GV GERLACH EH HINDLER J ERWIN ME
Citation: Rn. Jones et al., VALIDATION OF NCCLS MACROLIDE (AZITHROMYCIN, CLARITHROMYCIN, AND ERYTHROMYCIN) INTERPRETIVE CRITERIA FOR HAEMOPHILUS-INFLUENZAE TESTED WITHTHE HAEMOPHILUS TEST MEDIUM, Diagnostic microbiology and infectious disease, 18(4), 1994, pp. 243-249
IN-VITRO ACTIVITY OF 5 BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATIONS AGAINST CONSECUTIVE ISOLATES OF THE ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA/
Authors: MCLAUGHLIN JC BARRY AL FUCHS PC GERLACH EH HARDY DJ PFALLER MA
Citation: Jc. Mclaughlin et al., IN-VITRO ACTIVITY OF 5 BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATIONS AGAINST CONSECUTIVE ISOLATES OF THE ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA/, Journal of antimicrobial chemotherapy, 33(2), 1994, pp. 223-230
IN-VITRO COMPARISON ACTIVITY OF OPC-17116, A NEW FLUOROQUINOLONE, AGAINST MORE THAN 5,000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: SADER HS JONES RN ALLEN SD GERLACH EH MURRAY PR WASHINGTON JA
Citation: Hs. Sader et al., IN-VITRO COMPARISON ACTIVITY OF OPC-17116, A NEW FLUOROQUINOLONE, AGAINST MORE THAN 5,000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Journal of chemotherapy, 5(5), 1993, pp. 283-288
INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR DETERMINING BACTERIAL SUSCEPTIBILITY TO FOSFOMYCIN TROMETHAMINE
Authors: BARRY AL PFALLER MA FUCHS PC TENOVER FC RELLER LB ALLEN SD HARDY DJ GERLACH EH
Citation: Al. Barry et al., INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR DETERMINING BACTERIAL SUSCEPTIBILITY TO FOSFOMYCIN TROMETHAMINE, European journal of clinical microbiology & infectious diseases, 12(5), 1993, pp. 352-356
COMPARISON OF FIXED CONCENTRATION AND FIXED-RATIO OPTIONS FOR DILUTION SUSCEPTIBILITY TESTING OF GRAM-NEGATIVE BACILLI TO AMPICILLIN AND AMPICILLIN-SULBACTAM
Authors: PFALLER MA BARRY AL FUCHS PC GERLACH EH HARDY DJ MCLAUGHLIN JC
Citation: Ma. Pfaller et al., COMPARISON OF FIXED CONCENTRATION AND FIXED-RATIO OPTIONS FOR DILUTION SUSCEPTIBILITY TESTING OF GRAM-NEGATIVE BACILLI TO AMPICILLIN AND AMPICILLIN-SULBACTAM, European journal of clinical microbiology & infectious diseases, 12(5), 1993, pp. 356-362
IN-VITRO COMPARISON OF E4868, A NEW TRIFLUOROQUINOLONE, WITH CIPROFLOXACIN AND TEMAFLOXACIN TESTED AGAINST 5192 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: MURRAY PR JONES RN WASHINGTON JA GERLACH EH ALLEN SD
Citation: Pr. Murray et al., IN-VITRO COMPARISON OF E4868, A NEW TRIFLUOROQUINOLONE, WITH CIPROFLOXACIN AND TEMAFLOXACIN TESTED AGAINST 5192 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Diagnostic microbiology and infectious disease, 17(4), 1993, pp. 307-311
IN-VITRO ACTIVITY OF CEFPODOXIME COMPARED WITH OTHER ORAL CEPHALOSPORINS TESTED AGAINST 5556 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: SADER HS JONES RN WASHINGTON JA MURRAY PR GERLACH EH ALLEN SD ERWIN ME
Citation: Hs. Sader et al., IN-VITRO ACTIVITY OF CEFPODOXIME COMPARED WITH OTHER ORAL CEPHALOSPORINS TESTED AGAINST 5556 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Diagnostic microbiology and infectious disease, 17(2), 1993, pp. 143-150
IN-VITRO ACTIVITY OF AMPICILLIN, AMOXICILLIN, AMPICILLIN-SULBACTAM, AND AMOXICILLIN-CLAVULANIC ACID AGAINST CONSECUTIVE CLINICAL ISOLATES OF ENTEROBACTERIACEAE
Authors: FUCHS PC BARRY AL PFALLER MA HARDY DJ MCLAUGHLIN JC GERLACH EH
Citation: Pc. Fuchs et al., IN-VITRO ACTIVITY OF AMPICILLIN, AMOXICILLIN, AMPICILLIN-SULBACTAM, AND AMOXICILLIN-CLAVULANIC ACID AGAINST CONSECUTIVE CLINICAL ISOLATES OF ENTEROBACTERIACEAE, Diagnostic microbiology and infectious disease, 17(2), 1993, pp. 171-175
IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICALISOLATES
Authors: MARSHALL SA JONES RN MURRAY PR WASHINGTON JA ALLEN SD GERLACH EH ERWIN ME
Citation: Sa. Marshall et al., IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICALISOLATES, Journal of antimicrobial chemotherapy, 32(6), 1993, pp. 877-884
QUALITY-CONTROL GUIDELINES FOR CEFDINIR, CEFEPIME, CEFETAMET, CEFMETAZOLE, CEFPODOXIME, CEFPROZIL, AND CLINAFLOXACIN (CI-960) FOR VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TESTING METHODS
Authors: BALE MJ JONES RN MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., QUALITY-CONTROL GUIDELINES FOR CEFDINIR, CEFEPIME, CEFETAMET, CEFMETAZOLE, CEFPODOXIME, CEFPROZIL, AND CLINAFLOXACIN (CI-960) FOR VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TESTING METHODS, Journal of clinical microbiology, 31(9), 1993, pp. 2538-2540
MULTICENTER COMPARISON OF IN-VITRO ACTIVITIES OF FK-037, CEFEPIME, CEFTRIAXONE, CEFTAZIDIME, AND CEFUROXIME
Authors: WASHINGTON JA JONES RN GERLACH EH MURRAY PR ALLEN SD KNAPP CC
Citation: Ja. Washington et al., MULTICENTER COMPARISON OF IN-VITRO ACTIVITIES OF FK-037, CEFEPIME, CEFTRIAXONE, CEFTAZIDIME, AND CEFUROXIME, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1696-1700
Risultati: 1-16 |